drugset / Trial / NCT01605617

Trial of Percutaneous Tibial Nerve Stimulation (PTNS) Versus PTNS and Fesoterodine Fumarate

NCT01605617

Phase 4 Terminated 4 enrolled Mayo Clinic
RandomizedCrossoverDouble-blindTreatment

Summary

The investigators are studying two FDA-approved modalities used to treat overactive bladder to determine if they improve overactive bladder with or without urge incontinence when used together rather than separately, percutaneous tibial nerve stimulation (PTNS) versus PTNS and fesoterodine fumarate.

Timeline

Start
2012-06
Primary completion
2013-03
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fesoterodine Other / unclassified 4 mg

Indications